SMG vs SPB vs CENT vs ANDE vs AMGN

For growth investors, Amgen Inc.

(AMGN) is the stronger pick with 9. 9% revenue growth year-over-year, versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). Central Garden & Pet Company (CENT) offers the better valuation at 15. 1x trailing P/E (13. 5x forward), making it the more compelling value choice. Analysts rate The Scotts Miracle-Gro Company (SMG) a "Buy" — based on 17 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Central Garden & Pet Company (CENT) is the cheapest at 15.

1x versus The Andersons, Inc. at 25. 3x. On forward P/E, Central Garden & Pet Company is actually cheaper at 13. 5x. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: The Andersons, Inc. wins at 0. 22x versus Amgen Inc. 's 5. 01x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.

Over the past 5 years, The Andersons, Inc.

(ANDE) delivered a total return of +141. 6%, compared to -69. 1% for The Scotts Miracle-Gro Company (SMG). Over 10 years, the gap is even starker: ANDE returned +192. 1% versus SPB's +11. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), The Andersons, Inc.

(ANDE) is the lower-risk stock at 0. 55β versus The Scotts Miracle-Gro Company's 1. 10β — meaning SMG is approximately 100% more volatile than ANDE relative to the S&P 500. On balance sheet safety, Spectrum Brands Holdings, Inc. (SPB) carries a lower debt/equity ratio of 34% versus 6% for Amgen Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Amgen Inc.

(AMGN) is pulling ahead at 9. 9% versus -5. 2% for Spectrum Brands Holdings, Inc. (SPB). On earnings-per-share growth, the picture is similar: The Scotts Miracle-Gro Company grew EPS 504. 9% year-over-year, compared to -15. 7% for The Andersons, Inc.. Over a 3-year CAGR, AMGN leads at 11. 8% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Amgen Inc.

(AMGN) is the more profitable company, earning 21. 0% net margin versus 0. 9% for The Andersons, Inc. — meaning it keeps 21. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: AMGN leads at 29. 1% versus 1. 2% for ANDE. At the gross margin level — before operating expenses — AMGN leads at 70. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.

By this metric, The Andersons, Inc. (ANDE) is the more undervalued stock at a PEG of 0. 22x versus Amgen Inc. 's 5. 01x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Central Garden & Pet Company (CENT) trades at 13. 5x forward P/E versus 14. 8x for Spectrum Brands Holdings, Inc. — 1. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CENT: 32. 4% to $51. 00.

In this comparison, SMG (4.

2% yield), AMGN (2. 9% yield), SPB (2. 4% yield), ANDE (1. 1% yield) pay a dividend. CENT does not pay a meaningful dividend and should not be held primarily for income.

For long-horizon retirement investors, The Andersons, Inc.

(ANDE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 55), 1. 1% yield, +192. 1% 10Y return). Both have compounded well over 10 years (ANDE: +192. 1%, CENT: +161. 6%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

These companies operate in different sectors (SMG (Basic Materials) and SPB (Consumer Defensive) and CENT (Consumer Defensive) and ANDE (Consumer Defensive) and AMGN (Healthcare)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.

In terms of investment character: SMG is a small-cap income-oriented stock; SPB is a small-cap quality compounder stock; CENT is a small-cap deep-value stock; ANDE is a small-cap quality compounder stock; AMGN is a mid-cap quality compounder stock. SMG, SPB, ANDE, AMGN pay a dividend while CENT does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.